Combination of the CCL5-Derived Peptide R4.0 With Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.03559-14
Full Text
Open PDFAbstract
Available in full text
Date
August 11, 2014
Authors
Publisher
American Society for Microbiology